# CX-101 Cellular Assay

## Overview

This project contains the data processing, quality control, analysis, and visualization workflow for a fictional concentration-response assay investigating the effect of CX-101 on intracellular calcium signaling in cultured human skeletal muscle cells.

The assay measures intracellular calcium response across a concentration range of 0–1000 nM, using vehicle-treated cells as a negative control and ionomycin as a positive control.

The project is designed to demonstrate a reproducible workflow for processing heterogeneous experimental data from multiple assay batches, performing quality control, generating an analysis-ready dataset, and producing concentration-response and batch-level visualizations.


## Fictional Experiment Design

Treatment conditions

| Condition | Concentration |

|-------------------|-------------------|

| Vehicle control | 0 nM |
| CX-101 | 0.1 nM |
| CX-101 | 1 nM |
| CX-101 | 10 nM |
| CX-101 | 100 nM |
| CX-101 | 1000 nM |
| Ionomycin control | Positive control |

The experiment contains measurements from multiple experimental batches with biological/technical replicates.

The primary measurement is relative fluorescence units (RFU) representing the intracellular calcium response.


## Project Objectives

The analysis workflow addresses the following objectives:

**Implemented, prelim version:**
1. Consolidate raw assay data from multiple Excel files.
2. Standardize column names, identifiers, concentrations, and units.
3. Perform systematic data-quality checks.
4. Identify missing, duplicated, inconsistent, or potentially anomalous observations.
5. Generate a documented analysis-ready dataset.
**Planned:**
6. Normalize CX-101 responses relative to the vehicle control.
7. Summarize the response at each concentration.
8. Assess variability within and between experimental batches.
9. Visualize the concentration-response relationship.
10. Export analysis results and figures for reporting.



## Reproducibility

The analysis is intended to be reproducible from the raw input data.

The general principle is:

Raw data → standardized data → QC → analysis dataset → analysis → visualization

Raw Excel files should remain unchanged. Any transformation required for analysis should be performed programmatically and documented in the notebook or source code.

This approach preserves the distinction between the original experimental data and derived analytical datasets.


## Scope and Limitations

This repository represents a fictional assay dataset and analysis workflow developed for demonstrating data-analysis and automation practices in a pharmaceutical/biotechnology context.

The results should therefore be interpreted as an example of an analytical workflow rather than as experimental evidence regarding the biological activity of a real compound.

